FDA Approved: SYMDEKO — Supplemental Application (Vertex Pharmaceuticals Incorporated)

View source ↗

Summary

FDA approved Vertex's supplemental application for SYMDEKO (tezacaftor and ivacaftor). The approval updates the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Symdeko (tezacaftor/ivacaftor)

Snippet

SUPPL AP for SYMDEKO (TEZACAFTOR AND IVACAFTOR)